How the Shift to Telehealth Affected Health Care Methods for Patients With Diabetes
Mary Reed, DrPH, research scientist at Kaiser Permanente, discussed how COVID-19 forced health systems to shift primarily to telehealth, and the impact this had on patients with diabetes.
Pharmacy Times interviewed Mary Reed, DrPH, research scientist at Kaiser Permanente, on the subject of her 2021 ADA conference session, "Reimagining Diabetes Care in the Virtual World."
In this discussion, Reed discussed how patient care for diabetes moved to a virtual environment during the COVID-19 pandemic, requiring providers to essentially conduct a mandatory pilot of shifting to telehealth for outpatient care. Further, there were disparities across health systems in terms of preexisting telehealth tools in use, causing the shift to affect each facility differently.